🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
0.1636
-0.0230 (-12.33%)
At close: Nov 20, 2026, 4:00 PM EST
0.1666
+0.0030 (1.83%)
After-hours: Nov 20, 2026, 7:46 PM EST

Vistagen Therapeutics Revenue

Vistagen Therapeutics had revenue of $138.00K in the quarter ending September 30, 2026, a decrease of -46.51%. This brings the company's total for the last twelve months to $2.38M, up 230.37% year-over-year. In the fiscal year ending March 31, 2026, Vistagen Therapeutics had annual revenue of $1.27M with 161.11% growth. That makes Vistagen Therapeutics the 42,051st largest company in the world by revenue and 5,700th in the United States.

Revenue (ttm)
$2.38M
Revenue Growth
+230.37%
P/S Ratio
3.17
Revenue / Employee
$58,073
Employees
41
Market Cap
7.56M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20261.27M783.00K161.11%
Mar 31, 2025486.00K-578.00K-54.32%
Mar 31, 20241.06M1.29M-
Mar 31, 2023-227.00K-1.34M-
Mar 31, 20221.11M19.40K1.78%
Mar 31, 20211.09M--
Mar 31, 2020---
Mar 31, 2019---
Mar 31, 2018---
Mar 31, 20171.25M--
Mar 31, 2016---
Mar 31, 2015---
Mar 31, 2014---
Mar 31, 2013200.40K-1.14M-85.07%
Mar 31, 20121.34M-728.80K-35.19%
Mar 31, 20112.07M--
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Aligos Therapeutics33.65M
Radiopharm Theranostics8.90M
Immuron5.34M
BioLineRx1.39M
Lisata Therapeutics100.00K
Revenue Rankings